Literature DB >> 17235376

Heroin-Induces Differential Protein Expression by Normal Human Astrocytes (NHA).

Jessica L Reynolds1, Supriya D Mahajan, Donald Sykes, Madhavan P N Nair.   

Abstract

Heroin use is postulated to act as a cofactor in the neuropathogenesis of human immunodeficiency virus (HIV-1) infection. Astrocytes, integral components of the CNS, are reported to be susceptible to HIV-1 infection. Upon activation, astrocytes release a number of immunoregulatory products or modulate the expression of a number of proteins that foster the immunopathogenesis of HIV-1 infection. However, the role of heroin on HIV-1 infectivity and the expression of the proteome of normal human astrocytes (NHA) have not been elucidated. We hypothesize that heroin modulates the expression of a number of proteins by NHA that foster the neuoropathogenesis of HIV-1 infection. We utilized LTR amplification and the p24 antigen assay to quantitate the effect of heroin on HIV-1 infectivity while difference gel electrophoresis (DIGE) combined with protein identification through high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) to analyze the effects of heroin on the proteomic profile of NHA. Results demonstrate that heroin potentiates HIV-1 replication in NHA. Furthermore, heroin significantly increased protein expression levels for protein kinase C (PKC), reticulocalbin 1 precursor, reticulocalbin 1, tyrosine 3-monooxgenase/tryptophan 5-monooxgenase activation protein, chloride intracellular channel 1, cathepsin D preproprotein, galectin 1 and myosin light chain alkali. Heroin also significantly decreased protein expression for proliferating cell nuclear antigen, proteasome beta 6 subunit, tropomyosin 3, laminin receptor 1, tubulin alpha 6, vimentin, EF hand domain family member D2, Tumor protein D54 (hD54), ATP synthase, H+ transporting, mitochondrial F1 complex and ribosomal protein S14. Identification of unique, heroin-induced proteins may help to develop novel markers for diagnostic, preventative and therapeutic targeting in heroin using subjects.

Entities:  

Year:  2006        PMID: 17235376      PMCID: PMC1775911          DOI: 10.3844/ajidsp.2006.49.57

Source DB:  PubMed          Journal:  Am J Infect Dis        ISSN: 1553-6203


  56 in total

Review 1.  Current concepts in human immunodeficiency virus infection and AIDS.

Authors:  S A Schwartz; M P Nair
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity.

Authors:  F Gharahdaghi; C R Weinberg; D A Meagher; B S Imai; S M Mische
Journal:  Electrophoresis       Date:  1999-03       Impact factor: 3.535

Review 3.  Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis.

Authors:  R Brack-Werner
Journal:  AIDS       Date:  1999-01-14       Impact factor: 4.177

4.  Intermediate filament assembly and stability in vitro: effect and implications of the removal of head and tail domains of vimentin by the human immunodeficiency virus type 1 protease.

Authors:  R L Shoeman; E Mothes; C Kesselmeier; P Traub
Journal:  Cell Biol Int Rep       Date:  1990-07

5.  Proteomics analysis of human astrocytes expressing the HIV protein Tat.

Authors:  Chava B Pocernich; Debra Boyd-Kimball; H Fai Poon; Visith Thongboonkerd; Bert C Lynn; Jon B Klein; Vittorio Calebrese; Avindra Nath; D Allan Butterfield
Journal:  Brain Res Mol Brain Res       Date:  2005-02-18

6.  Cleavage of vimentin by different retroviral proteases.

Authors:  J Snásel; R Shoeman; M Horejsí; O Hrusková-Heidingsfeldová; J Sedlácek; T Ruml; I Pichová
Journal:  Arch Biochem Biophys       Date:  2000-05-15       Impact factor: 4.013

Review 7.  The neuropathogenesis of AIDS.

Authors:  Francisco González-Scarano; Julio Martín-García
Journal:  Nat Rev Immunol       Date:  2005-01       Impact factor: 53.106

8.  Assessment by flow cytometry of peripheral blood leukocyte enzymatic activities in HIV patients.

Authors:  C Prin-Mathieu; V Baty; G Faure; H Schumacher; M N Kolopp-Sarda; T May; P Canton; M C Béné
Journal:  J Immunol Methods       Date:  2001-06-01       Impact factor: 2.303

9.  Antiviral drugs from the nucleoside analog family block volume-activated chloride channels.

Authors:  M Gschwentner; A Susanna; E Wöll; M Ritter; U O Nagl; A Schmarda; A Laich; G M Pinggera; H Ellemunter; H Huemer
Journal:  Mol Med       Date:  1995-05       Impact factor: 6.354

10.  HIV infection among persons who inject illicit drugs: problems and prospects.

Authors:  D C Des Jarlais; S R Friedman
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988
View more
  9 in total

Review 1.  Opioids and HIV/HCV infection.

Authors:  Xu Wang; Ting Zhang; Wen-Zhe Ho
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-14       Impact factor: 4.147

Review 2.  Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.

Authors:  Anupam Banerjee; Marianne Strazza; Brian Wigdahl; Vanessa Pirrone; Olimpia Meucci; Michael R Nonnemacher
Journal:  J Neurovirol       Date:  2011-07-07       Impact factor: 2.643

Review 3.  Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.

Authors:  Xu Wang; Wen-Zhe Ho
Journal:  Life Sci       Date:  2010-11-04       Impact factor: 5.037

4.  Morphine and galectin-1 modulate HIV-1 infection of human monocyte-derived macrophages.

Authors:  Jessica L Reynolds; Wing Cheung Law; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Manoj J Mammen; Ken-Tye Yong; Rui Hui; Paras N Prasad; Stanley A Schwartz
Journal:  J Immunol       Date:  2012-03-19       Impact factor: 5.422

5.  Galectin-1 Reduces Neuroinflammation via Modulation of Nitric Oxide-Arginase Signaling in HIV-1 Transfected Microglia: a Gold Nanoparticle-Galectin-1 "Nanoplex" a Possible Neurotherapeutic?

Authors:  Ravikumar Aalinkeel; Courtney S Mangum; Eliane Abou-Jaoude; Jessica L Reynolds; Maixian Liu; Karin Sundquist; Neil U Parikh; Lee D Chaves; Manoj J Mammen; Stanley A Schwartz; Supriya D Mahajan
Journal:  J Neuroimmune Pharmacol       Date:  2016-12-27       Impact factor: 4.147

6.  The Mycobacterium bovis bacille Calmette-Guerin phagosome proteome.

Authors:  Bai-Yu Lee; Deepa Jethwaney; Birgit Schilling; Daniel L Clemens; Bradford W Gibson; Marcus A Horwitz
Journal:  Mol Cell Proteomics       Date:  2009-10-07       Impact factor: 5.911

Review 7.  Proteomics, biomarkers, and HIV-1: A current perspective.

Authors:  Maire Rose Donnelly; Pawel Ciborowski
Journal:  Proteomics Clin Appl       Date:  2015-07-08       Impact factor: 3.494

8.  Serum proteomic analysis reveals high frequency of haptoglobin deficiency and elevated thyroxine level in heroin addicts.

Authors:  Bing-Ying Zhou; Shi-Yan Yan; Wan-Lu Shi; Zhi Qu; Xin Zhao; Zhi-Min Liu; Xiao-Ping Pu
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

9.  Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages.

Authors:  Xu Wang; Tong-Cui Ma; Jie-Liang Li; Yu Zhou; Ellen B Geller; Martin W Adler; Jin-Song Peng; Wang Zhou; Dun-Jin Zhou; Wen-Zhe Ho
Journal:  Front Microbiol       Date:  2015-11-04       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.